Anyone have a good clue what new law he is talking about?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I don’t know, but I will guess.
Late in 2022…
Section 3209 of the bill amends the Federal Food, Drug, and Cosmetics Act (FFDCA) to specify “nonclinical tests” instead of “preclinical tests.” It also swaps the term “animal” for “nonclinical tests” and adds new text identifying that “nonclinical tests” may incorporate human-relevant testing methods. Those methods may include cell-based assays, bioprinted models and microphysiological systems, including organ-chips or computer models.
A growing number of companies are working on developing AI-models that could reduce or replace the need for animal testing in some situations in the coming years.
The federal mandate for animal testing has been U.S. law since 1938.
The FDA Modernization Act 2.0 won support from more than 200 organizations. Generics giant Teva was the only pharma backer.
All of the above is from https://www.drugdiscoverytrends.com/congress-passes-fda-act-that-would-do-away-with-animal-testing-requirement
The part about only one pharma backing the act surprised me, but I suppose there was a lot more in it than just the part about animal testing.
Thanks for the tip. That makes sense.